Plexpress, ValiRx deal

ValiRx acquired all Plexpress assets and IP, specifically its Transcript Analysis

Read the full 110 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE